Prescribing guidelines for severe Pseudomonas infections.
about
Comparative analysis of solar pasteurization versus solar disinfection for the treatment of harvested rainwaterOuter membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein.Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy.Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa.Nosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance.Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms.Treatment of Pseudomonas aeruginosa infection in critically ill patients.Vancomycin-Resistant Pseudomonas Aeroginosa in the Cases of Trauma.Pseudomonas skin infection: clinical features, epidemiology, and management.Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.Detection and Genetic Characterization of Metallo-β-Lactamase IMP-1 and VIM-2 in Pseudomonas aeruginosa Strains From Different Hospitals in Kermanshah, Iran.Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection.In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.Pseudomonas bronchopulmonary infections in a palliative care setting.Carbohydrate hydrogels with stabilized phage particles for bacterial biosensing: bacterium diffusion studies.Novel drug targets in cell wall biosynthesis exploited by gene disruption in Pseudomonas aeruginosa.Multiresistant Stenotrophomonas maltophilia tunneled CVC-related sepsis, treated with systemic and lock therapy.Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.Pseudomonas aeruginosa intensive care unit outbreak: winnowing of transmissions with molecular and genomic typing.Antibiotic synergy interaction against multidrug-resistant Pseudomonas aeruginosa isolated from an abattoir effluent environment.
P2860
Q28817646-ED7C93F6-18E6-4AC4-B467-BB0ACA45DAC4Q33726558-5A0B2588-5AF5-409C-8BF6-2378772CDFABQ34782040-36E13D06-230A-48FF-8A6E-74F6A4537045Q34999695-ACA19662-3DD7-45E5-B13F-FBC71D9EEDE2Q36237707-7F0EF855-4388-46E1-B2BE-4943B84C2E51Q36246210-9BA9CEC2-C9A9-47B6-87B9-9B0C438FB17CQ36607415-CD134124-85C1-47D7-AD9C-E3F46036A094Q36654697-98184EC0-19BA-4C07-9C8F-5C670358EC8DQ37862227-EC9D5C6F-00EC-4130-A197-664ED91C2C3CQ40282230-1FEE3595-B9E9-4799-A8A4-63EE37B44907Q41191450-D7C23B9D-3DBE-4FEE-8450-3ED6D5BA7375Q41512238-86B1BC3A-A723-4A37-9401-78907F3114F5Q41577365-083AAD5C-748C-4FDA-8CEF-18EDA701BBFFQ42244620-402765B4-823F-4042-8B4E-CB66C5AC1DD4Q42260718-CA4D9E75-E682-4580-AAD7-B5842D187AFAQ42680076-F9DCF485-3629-4FB6-9CAC-AEA875DAAAC8Q45164111-81DEE049-630E-45AD-81BE-75EA72CEA038Q47218700-F3189F99-26BE-4B1B-9D7C-7B4F28FEFAA2Q47760001-A4400CB9-E575-411D-8AC5-62570B0BBC83Q54308245-C05366F1-1523-4E4D-8E2D-DC55ADE12790
P2860
Prescribing guidelines for severe Pseudomonas infections.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prescribing guidelines for severe Pseudomonas infections.
@ast
Prescribing guidelines for severe Pseudomonas infections.
@en
Prescribing guidelines for severe Pseudomonas infections.
@nl
type
label
Prescribing guidelines for severe Pseudomonas infections.
@ast
Prescribing guidelines for severe Pseudomonas infections.
@en
Prescribing guidelines for severe Pseudomonas infections.
@nl
prefLabel
Prescribing guidelines for severe Pseudomonas infections.
@ast
Prescribing guidelines for severe Pseudomonas infections.
@en
Prescribing guidelines for severe Pseudomonas infections.
@nl
P356
P1476
Prescribing guidelines for severe Pseudomonas infections.
@en
P2093
Helen Giamarellou
P304
P356
10.1093/JAC/49.2.229
P407
P577
2002-02-01T00:00:00Z